HomeBVS • NASDAQ
add
Bioventus Inc
Previous close
$7.56
Day range
$7.39 - $7.66
Year range
$5.81 - $11.89
Market cap
625.69M USD
Avg Volume
348.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 138.65M | -0.23% |
Operating expense | 82.96M | -5.01% |
Net income | 3.16M | 161.08% |
Net profit margin | 2.28 | 161.29% |
Earnings per share | 0.15 | 150.00% |
EBITDA | 22.67M | 22.62% |
Effective tax rate | 14.22% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 42.16M | -2.11% |
Total assets | 701.59M | -8.82% |
Total liabilities | 494.34M | -15.16% |
Total equity | 207.26M | — |
Shares outstanding | 66.98M | — |
Price to book | 3.05 | — |
Return on assets | 4.00% | — |
Return on capital | 5.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 3.16M | 161.08% |
Cash from operations | 30.10M | 191.76% |
Cash from investing | -473.00K | -639.06% |
Cash from financing | -19.98M | -5,618.51% |
Net change in cash | 9.25M | -16.48% |
Free cash flow | 29.02M | 109.70% |
About
Founded
2011
Website
Employees
950
